speb/financial-data huggingface dataset:
Financial ratios for GEG — annual report dated 2025-06-30
Total revenue: 16316000
Gross profit: -108000
Operating income: -8003000
Net income: 15550000
Capital expenditures: 0
Operating cash flow: -9006000
Depreciation & amortization: 1249000
Net tangible assets: 57869000
Owner earnings: 16799000
Return on net tangible assets (%): 29.029359415230953
Buffett classification: The Gruesome
Stock price: 2.07
P/E ratio: 4.17421264051447
Shares outstanding: 31357008
Book value: 80666000
P/B ratio: 0.8046637562293902
Market cap (USD): 64909006.559999995
Debt to equity: 0.7759155034339127
Current ratio: 14.343353442895777
Quick ratio: 13.398377366340753
Effective tax rate (%): 0.5500127909951394
Interest coverage ratio: -1.9251864325234544
COGS to revenue (%): 100.66192694287817
SG&A to revenue (%): 40.371414562392744
Free cash flow (dilution-adjusted): -10958000
Buyback yield (%): 11.152535501076386
Retained earnings: -3240063000
Inventory turnover: 1.8078150798018713
Receivables turnover: 0.9990815014389811
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.545200695661815
FCF margin (%): -67.16106888943368
Revenue growth (%): -8.511831333408097
Rule of 40 score: -75.67290022284178
Financial ratios for GEG — quarterly report dated 2025-06-30
Total revenue: 5608000
Gross profit: 788000
Operating income: -1475000
Net income: 15723000
Capital expenditures: 0
Operating cash flow: 2170000
Depreciation & amortization: 331000
Net tangible assets: 57869000
Owner earnings: 16054000
Return on net tangible assets (%): 27.741968929824257
Buffett classification: The Gruesome
Stock price: 2.07
P/E ratio: 5.782024457509353
Shares outstanding: 31357008
Book value: 80666000
P/B ratio: 0.8046637562293902
Market cap (USD): 64909006.559999995
Debt to equity: 0.7759155034339127
Current ratio: 14.343353442895777
Quick ratio: 13.398377366340753
Effective tax rate (%): 0.5439939275096464
Interest coverage ratio: -1.3915094339622642
COGS to revenue (%): 85.94864479315264
SG&A to revenue (%): 34.11198288159772
Free cash flow (dilution-adjusted): 1730000
Buyback yield (%): 1.420450025140548
Retained earnings: -3240063000
Inventory turnover: 0.5305448541552009
Receivables turnover: 0.34339599534627396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.022013123341394
FCF margin (%): 30.848787446504993
Revenue growth (%): 74.7584917419757
Rule of 40 score: 105.6072791884807
Financial ratios for GEG — quarterly report dated 2025-09-30
Total revenue: 10788000
Gross profit: -1197000
Operating income: -3726000
Net income: -7030000
Capital expenditures: 0
Operating cash flow: 3814000
Depreciation & amortization: 342000
Net tangible assets: 61620000
Owner earnings: -6688000
Return on net tangible assets (%): -10.853618954884778
Buffett classification: The Gruesome
Stock price: 2.45
P/E ratio: 18.30902516682555
Shares outstanding: 31357008
Book value: 83143000
P/B ratio: 0.9240064659682715
Market cap (USD): 76824669.60000001
Debt to equity: 0.7529196685229064
Current ratio: 16.677419354838708
Quick ratio: 16.134647550776585
Interest coverage ratio: -3.624513618677043
COGS to revenue (%): 111.09566184649611
SG&A to revenue (%): 20.077864293659623
Free cash flow (dilution-adjusted): 3170000
Buyback yield (%): 0.9840589018296277
Retained earnings: -3247093000
Inventory turnover: 2.6381245872771295
Receivables turnover: 2.1860182370820667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5409165302782326
FCF margin (%): 29.38450129773823
Revenue growth (%): 92.36804564907276
Rule of 40 score: 121.75254694681098
Financial ratios for GEG — quarterly report dated 2025-12-31
Total revenue: 3011000
Gross profit: -1924000
Operating income: -4233000
Net income: -15754000
Capital expenditures: 0
Operating cash flow: -1891000
Depreciation & amortization: 312000
Net tangible assets: 43888000
Owner earnings: -15442000
Return on net tangible assets (%): -35.18501640539555
Buffett classification: The Gruesome
Stock price: 2.55
Shares outstanding: 31357008
Book value: 59690000
P/B ratio: 1.3395940760596414
Market cap (USD): 79960370.39999999
Debt to equity: 1.0635952420841013
Current ratio: 10.319431360794725
Quick ratio: 9.796865633296223
Interest coverage ratio: -4.14187866927593
COGS to revenue (%): 163.89903686482896
SG&A to revenue (%): 65.65924941879774
Free cash flow (dilution-adjusted): -2454000
Buyback yield (%): 3.27537252128587
Retained earnings: -3262847000
Inventory turnover: 0.8087512291052114
Receivables turnover: 0.8253837719298246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.418920774406151
FCF margin (%): -81.50116240451678
Revenue growth (%): -72.08935854653319
Rule of 40 score: -153.59052095104997
Financial ratios for HGO.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.03623188405797102
Shares outstanding: 3539277407
Market cap (USD): 128234688.65942033
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HGO.AX — annual report dated 2022-12-31
Operating income: -3082432.4324324327
Net income: -4035810.810810811
Capital expenditures: 4911486.486486486
Depreciation & amortization: 45270.27027027027
Net tangible assets: 22004054.054054055
Owner earnings: -8902027.027027026
Return on net tangible assets (%): -40.45630412086224
Buffett classification: The Gruesome
Stock price: 0.033783783783783786
Shares outstanding: 3539277407
Book value: 22004054.05405405
P/B ratio: 5.434006950500523
Market cap (USD): 119570182.66891892
Debt to equity: 0
Current ratio: 3.105065666041276
Quick ratio: 2.9127579737335836
Interest coverage ratio: -3.1139931740614335
Free cash flow (dilution-adjusted): -9001351.35135135
Buyback yield (%): 0.012997003260897541
Retained earnings: -170885135.13513514
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.986152421848839
Rule of 40 score: 0
Financial ratios for HGO.AX — annual report dated 2023-12-31
Gross profit: -3417808.2191780824
Operating income: -10763698.630136987
Net income: -11182876.712328767
Capital expenditures: 14910273.97260274
Depreciation & amortization: 510958.90410958906
Net tangible assets: 37586301.36986301
Owner earnings: -25582191.78082192
Return on net tangible assets (%): -68.06254100153073
Buffett classification: The Gruesome
Stock price: 0.06164383561643835
Shares outstanding: 3539277407
Book value: 37586301.36986302
P/B ratio: 5.804631653728405
Market cap (USD): 218174634.67808217
Debt to equity: 0.2699540782855893
Current ratio: 0.6264460018576374
Quick ratio: 0.49400489740775144
Interest coverage ratio: -23.702865761689292
Free cash flow (dilution-adjusted): -21953424.657534245
Buyback yield (%): 0
Retained earnings: -184408904.10958904
Inventory turnover: 1.590691743704176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.311752769196968
Rule of 40 score: 0
Financial ratios for HGO.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 25820496.894409936
Buffett classification: The Gruesome
Stock price: 0.031055900621118012
Shares outstanding: 3539277407
Book value: 25820496.89440994
P/B ratio: 4.25690674628948
Market cap (USD): 109915447.42236024
Debt to equity: 0.3164465613047557
Current ratio: 0.3506041518590231
Quick ratio: 0.17095169236048138
Buyback yield (%): 0
Retained earnings: -182154037.26708072
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HGO.AX — annual report dated 2024-12-31
Total revenue: 69816149.06832297
Gross profit: 71238509.31677018
Operating income: -6465217.391304348
Net income: -14926086.956521738
Capital expenditures: 18478260.869565215
Depreciation & amortization: 19728571.42857143
Net tangible assets: 25820496.894409936
Owner earnings: -13675776.397515524
Return on net tangible assets (%): -52.96480719732505
Buffett classification: The Gruesome
Stock price: 0.031055900621118012
Shares outstanding: 3539277407
Book value: 25820496.89440994
P/B ratio: 4.25690674628948
Market cap (USD): 109915447.42236024
Debt to equity: 0.3164465613047557
Current ratio: 0.3506041518590231
Quick ratio: 0.17095169236048138
Interest coverage ratio: -0.7839283024551891
COGS to revenue (%): -2.0372940464752145
Free cash flow (dilution-adjusted): -6968322.981366459
Buyback yield (%): 0
Retained earnings: -182154037.26708072
Inventory turnover: -0.31241473396998637
Receivables turnover: 32.07876712328767
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.632884777123632
FCF margin (%): -9.980961531618092
Rule of 40 score: -9.980961531618092
Financial ratios for INDNIPPON.NS — annual report dated 2022-03-31
Total revenue: 73490702.88803904
Gross profit: 20163523.67137017
Operating income: 4845048.133983912
Net income: 6626664.90834762
Capital expenditures: 437821.4427007781
Operating cash flow: 929711.1960965317
Depreciation & amortization: 1694579.98153765
Net tangible assets: 66395885.53343004
Owner earnings: 7883423.447184492
Return on net tangible assets (%): 11.87336140462382
Capex to operating income (%): 9.036472509526401
Buffett classification: The Great
Stock price: 5.197679018857972
P/E ratio: 17.743299612656717
Shares outstanding: 22621424
Book value: 66621389.95120665
P/B ratio: 1.7648821345157268
Market cap (USD): 117578900.90149018
Debt to equity: 0.007739662305271284
Current ratio: 3.25854602414079
Quick ratio: 2.8015295310052517
Effective tax rate (%): 18.34579135521612
Interest coverage ratio: 85.44186046511629
COGS to revenue (%): 72.56316393913293
R&D to revenue (%): 0.47193511340798167
SG&A to revenue (%): 1.796224519092736
Free cash flow (dilution-adjusted): -2727152.8418831597
Buyback yield (%): 0
Retained earnings: 42015033.62785178
Inventory turnover: 8.15282258064516
Receivables turnover: 4.7203117059122475
Capitalized R&D asset: 346828.4320189899
ROCI (R&D-adjusted, %): 7.192192472736558
FCF margin (%): -3.7108814240597185
Rule of 40 score: -3.7108814240597185
Financial ratios for INDNIPPON.NS — annual report dated 2023-03-31
Total revenue: 78710109.6224117
Gross profit: 22104750.3045067
Operating income: 5075517.661388551
Net income: 5874543.239951279
Capital expenditures: 3070645.5542021925
Operating cash flow: 6925700.36540804
Depreciation & amortization: 1780755.1766138857
Net tangible assets: 68056029.23264313
Owner earnings: 4584652.862362972
Return on net tangible assets (%): 6.736585889680352
Capex to operating income (%): 60.49916006719462
Buffett classification: The Good
Stock price: 3.826187576126675
P/E ratio: 14.733709146008707
Shares outstanding: 22621424
Book value: 68249695.49330086
P/B ratio: 1.2681933719629503
Market cap (USD): 86553811.46309379
Debt to equity: 0.0065140185247978865
Current ratio: 3.011694943172459
Quick ratio: 2.549991764124526
Effective tax rate (%): 20.17543859649123
Interest coverage ratio: 112.62162162162161
COGS to revenue (%): 71.91625013540491
R&D to revenue (%): 0.28318967518299004
SG&A to revenue (%): 3.2280528001733186
Free cash flow (dilution-adjusted): 3855054.8112058467
Buyback yield (%): 0
Retained earnings: 42132764.92082826
Inventory turnover: 8.289867998572957
Receivables turnover: 5.408972963923998
Capitalized R&D asset: 455273.9532286063
ROCI (R&D-adjusted, %): 6.989351244981151
Rosenberg metric: 5.597080440712662
FCF margin (%): 4.897788644558271
Revenue growth (%): 7.102132010254788
Rule of 40 score: 11.99992065481306
Financial ratios for INDNIPPON.NS — annual report dated 2024-03-31
Total revenue: 85945557.02122557
Gross profit: 24901067.274253506
Operating income: 6250149.898069313
Net income: 7111164.408202422
Capital expenditures: 2876843.7462525484
Operating cash flow: 7517687.972178918
Depreciation & amortization: 1809569.4927449333
Net tangible assets: 74565295.59899269
Owner earnings: 6043890.154694807
Return on net tangible assets (%): 8.105500160823414
Capex to operating income (%): 46.02839600920952
Buffett classification: The Good
Stock price: 7.866362763915547
P/E ratio: 25.023795992550777
Shares outstanding: 22621424
Book value: 74739177.35939561
P/B ratio: 2.380924351958702
Market cap (USD): 177948327.4203455
Debt to equity: 0.004717208182912154
Current ratio: 2.5122108723729015
Quick ratio: 2.106140659856757
Effective tax rate (%): 21.74716283979942
Interest coverage ratio: 157.93939393939394
COGS to revenue (%): 71.02692898004744
R&D to revenue (%): 0.36556439235384397
SG&A to revenue (%): 2.884051904562578
Free cash flow (dilution-adjusted): 4640844.22592637
Buyback yield (%): 0
Retained earnings: 45812447.53567574
Inventory turnover: 7.359404366054648
Receivables turnover: 5.056084656084656
Capitalized R&D asset: 577982.0013758781
ROCI (R&D-adjusted, %): 7.785890125831127
Rosenberg metric: 12.545225312361351
FCF margin (%): 5.3997488488907495
Revenue growth (%): 9.19252613612632
Rule of 40 score: 14.59227498501707
Financial ratios for INDNIPPON.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 79347826.08695652
Buffett classification: The Gruesome
Stock price: 8.869923554706164
Shares outstanding: 22621424
Book value: 79493549.92833254
P/B ratio: 2.5241079529029933
Market cap (USD): 200650301.5785953
Debt to equity: 0.0038315903353768484
Current ratio: 2.3787406667058617
Quick ratio: 1.9702510435651717
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDNIPPON.NS — quarterly report dated 2024-12-31
Total revenue: 25022729.921902318
Gross profit: 8263200.839258654
Operating income: 2247348.1757780625
Net income: 1860356.6849283131
Capital expenditures: 0
Depreciation & amortization: 751835.878307495
Owner earnings: 2612192.563235808
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.905233710222637
P/E ratio: 24.031365198245616
Shares outstanding: 22621424
Market cap (USD): 178827643.5780394
Effective tax rate (%): 24.71698113207547
Interest coverage ratio: 275.42857142857144
COGS to revenue (%): 66.9772208506079
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDNIPPON.NS — annual report dated 2025-03-31
Total revenue: 97257423.42763619
Gross profit: 28996960.486322187
Operating income: 8574935.702595277
Net income: 9618891.74655132
Capital expenditures: 2718026.654196867
Operating cash flow: 5793780.687397708
Depreciation & amortization: 2403553.892915595
Net tangible assets: 83026654.19686696
Owner earnings: 9304418.98527005
Return on net tangible assets (%): 11.206544543163291
Capex to operating income (%): 31.697341513292432
Buffett classification: The Good
Stock price: 6.888084957404598
P/E ratio: 16.19919367793459
Shares outstanding: 22621424
Book value: 83140051.43792377
P/B ratio: 1.8741663936281365
Market cap (USD): 155818290.36947137
Debt to equity: 0.002966900081554599
Current ratio: 2.379776505859907
Quick ratio: 1.9861542654674296
Effective tax rate (%): 20.062178179345185
Interest coverage ratio: 282.11538461538464
COGS to revenue (%): 70.18534990504122
R&D to revenue (%): 0.568550616631007
SG&A to revenue (%): 2.289828593408178
Free cash flow (dilution-adjusted): 3075754.0332008414
Buyback yield (%): 0
Retained earnings: 50973813.420621924
Inventory turnover: 8.086137654064535
Receivables turnover: 4.9038608900677865
Capitalized R&D asset: 837019.1755607422
ROCI (R&D-adjusted, %): 9.831224878560057
Rosenberg metric: 13.036508967725469
FCF margin (%): 3.1624876793999563
Revenue growth (%): 13.161665126699894
Rule of 40 score: 16.32415280609985
Financial ratios for INDNIPPON.NS — quarterly report dated 2025-03-31
Total revenue: 27327566.050970305
Gross profit: 8737432.779985972
Operating income: 2494739.303249941
Net income: 3158756.1374795414
Capital expenditures: 0
Depreciation & amortization: 744680.8510638297
Net tangible assets: 83026654.19686696
Owner earnings: 3903436.988543371
Return on net tangible assets (%): 4.701426338688557
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.888084957404598
P/E ratio: 12.332250701521634
Shares outstanding: 22621424
Book value: 83140051.43792377
P/B ratio: 1.8741663936281365
Market cap (USD): 155818290.36947137
Debt to equity: 0.002966900081554599
Current ratio: 2.379776505859907
Quick ratio: 1.9861542654674296
Effective tax rate (%): 9.63210702341137
Interest coverage ratio: 266.74999999999994
COGS to revenue (%): 68.02703627652292
Buyback yield (%): 0
Retained earnings: 50973813.420621924
Inventory turnover: 2.2021880625952086
Receivables turnover: 1.3778956675508398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.824881193492448
Revenue growth (%): 9.210969931184732
Rule of 40 score: 9.210969931184732
Financial ratios for INDNIPPON.NS — quarterly report dated 2025-06-30
Total revenue: 26293002.57430377
Gross profit: 8271706.061315236
Operating income: 2168265.855370934
Net income: 2715890.4750760593
Capital expenditures: 0
Depreciation & amortization: 492628.1301193541
Owner earnings: 3208518.6051954133
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.492979171542242
P/E ratio: 24.838164312757403
Shares outstanding: 22621424
Market cap (USD): 192123282.86262578
Effective tax rate (%): 23.776683087027912
Interest coverage ratio: 231.625
COGS to revenue (%): 68.54027592345349
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.7857871232912177
Rule of 40 score: -3.7857871232912177
Financial ratios for INDNIPPON.NS — quarterly report dated 2025-09-30
Total revenue: 30728297.632468995
Gross profit: 9344983.089064261
Operating income: 2847801.578354002
Net income: 2615558.060879369
Capital expenditures: 0
Depreciation & amortization: 481397.9706877114
Net tangible assets: 88388951.52198422
Owner earnings: 3096956.03156708
Return on net tangible assets (%): 3.503781839517353
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.998196166854566
P/E ratio: 21.85132060908398
Shares outstanding: 22621424
Book value: 88472378.80496053
P/B ratio: 2.556429902537114
Market cap (USD): 226173434.72559187
Debt to equity: 0.0021153233513857917
Current ratio: 2.4933235201345814
Quick ratio: 2.0287036063505415
Effective tax rate (%): 27.680798004987533
Interest coverage ratio: 315.74999999999994
COGS to revenue (%): 69.58834751981216
Buyback yield (%): 0
Inventory turnover: 2.1460737723466847
Receivables turnover: 1.3208626120668765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.022434938677834
Revenue growth (%): 16.868727889221194
Rule of 40 score: 16.868727889221194
Financial ratios for INDNIPPON.NS — quarterly report dated 2025-12-31
Total revenue: 30272919.68363596
Gross profit: 9520998.106271584
Operating income: 2770413.2783780773
Net income: 2777097.0257324274
Capital expenditures: 0
Depreciation & amortization: 499053.1357914671
Owner earnings: 3276150.1615238944
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.91444803386432
P/E ratio: 17.897586670188545
Shares outstanding: 22621424
Market cap (USD): 201657508.70001113
Effective tax rate (%): 25.135135135135133
Interest coverage ratio: 310.875
COGS to revenue (%): 68.54945540182514
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.4819498114723388
Rule of 40 score: -1.4819498114723388
Financial ratios for JYC.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.4586466165413532
Shares outstanding: 29569269
Market cap (USD): 43131114.180451125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JYC.AX — annual report dated 2022-06-30
Total revenue: 88976551.72413793
Gross profit: 46784827.5862069
Operating income: 12560000
Net income: 12144827.586206896
Capital expenditures: 2815172.4137931033
Depreciation & amortization: 3796551.724137931
Net tangible assets: 14434482.75862069
Owner earnings: 13126206.896551723
Return on net tangible assets (%): 90.93645484949832
Capex to operating income (%): 22.413793103448274
Buffett classification: The Great
Stock price: 1.2758620689655173
P/E ratio: 3.106368407155026
Shares outstanding: 29569269
Book value: 24871724.137931034
P/B ratio: 1.5168352831078085
Market cap (USD): 37726308.72413793
Debt to equity: 0.4251608251996451
Current ratio: 1.6678202792956889
Quick ratio: 1.5712204007285975
Effective tax rate (%): 32.91428571428572
COGS to revenue (%): 47.41892478452285
SG&A to revenue (%): 32.118496930613254
Free cash flow (dilution-adjusted): 14386206.896551725
Buyback yield (%): 0
Retained earnings: 5548275.862068966
Inventory turnover: 19.22627278441232
Receivables turnover: 83.94014313597918
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 33.81924198250729
FCF margin (%): 16.168537235691698
Rule of 40 score: 16.168537235691698
Financial ratios for JYC.AX — annual report dated 2023-06-30
Total revenue: 95828476.82119206
Gross profit: 51049668.87417219
Operating income: 14347682.119205298
Net income: 10845695.364238411
Capital expenditures: 2086754.9668874172
Depreciation & amortization: 4615231.78807947
Net tangible assets: 16717218.543046357
Owner earnings: 13374172.185430463
Return on net tangible assets (%): 80.00237689656538
Capex to operating income (%): 14.544195707362107
Buffett classification: The Great
Stock price: 1.3112582781456954
P/E ratio: 3.574961996702693
Shares outstanding: 29569269
Book value: 26562913.90728477
P/B ratio: 1.459664737471952
Market cap (USD): 38772948.754966885
Debt to equity: 0.475068561455996
Current ratio: 1.5191861140137004
Quick ratio: 1.4440961337513065
Effective tax rate (%): 31.76818598450129
COGS to revenue (%): 46.72808066288415
SG&A to revenue (%): 31.61139176647017
Free cash flow (dilution-adjusted): 13095364.238410596
Buyback yield (%): 0
Retained earnings: 7115231.78807947
Inventory turnover: 26.136838036335526
Receivables turnover: 136.63928234183192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.904589994842695
FCF margin (%): 13.665420418656401
Revenue growth (%): 7.700821131277112
Rule of 40 score: 21.366241549933513
Financial ratios for JYC.AX — annual report dated 2024-06-30
Total revenue: 97006000
Gross profit: 52119333.333333336
Operating income: 14411333.333333334
Net income: 11687333.333333334
Capital expenditures: 1460666.6666666667
Depreciation & amortization: 4976000
Net tangible assets: 17926000
Owner earnings: 15202666.666666668
Return on net tangible assets (%): 84.80791401688424
Capex to operating income (%): 10.135541471989638
Buffett classification: The Great
Stock price: 2.3066666666666666
P/E ratio: 5.835928968113627
Shares outstanding: 29569269
Book value: 25879333.33333333
P/B ratio: 2.6355565764187645
Market cap (USD): 68206447.16
Debt to equity: 0.7108889976557872
Current ratio: 1.4449953517198637
Quick ratio: 1.3243569879144719
Effective tax rate (%): 28.891863389308025
COGS to revenue (%): 46.27205190056972
SG&A to revenue (%): 32.274979554529274
Free cash flow (dilution-adjusted): 12375333.333333334
Buyback yield (%): 0
Retained earnings: 7402666.666666667
Inventory turnover: 17.29514513228872
Receivables turnover: 154.96166134185304
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 35.691642175477995
FCF margin (%): 12.757286490869982
Revenue growth (%): 1.2287821093150673
Rule of 40 score: 13.98606860018505
Financial ratios for KEC.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.866279836476329
Shares outstanding: 266200000
Market cap (USD): 1295403692.4699986
Buyback yield (%): 0
Retained earnings: 414908347.6196756
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEC.NS — annual report dated 2023-03-31
Total revenue: 2070255785.627284
Gross profit: 408436053.5931791
Operating income: 95803897.6857491
Net income: 21440925.70036541
Capital expenditures: 1914738.1242387334
Operating cash flow: 74755176.6138855
Depreciation & amortization: 19668696.71132765
Net tangible assets: 422705237.51522535
Owner earnings: 39194884.28745432
Return on net tangible assets (%): 9.272391446543779
Capex to operating income (%): 1.9986014875087406
Buffett classification: The Great
Stock price: 5.471863580998782
P/E ratio: 67.93597000511276
Shares outstanding: 266200000
Book value: 459370280.1461632
P/B ratio: 3.170884465574066
Market cap (USD): 1456610085.2618759
Debt to equity: 0.8971053420055524
Current ratio: 1.126105190240158
Quick ratio: 1.0373966577892608
Effective tax rate (%): -9.348987451857374
Interest coverage ratio: 1.4728297505804808
COGS to revenue (%): 80.2712275251812
SG&A to revenue (%): 3.889614515673538
Free cash flow (dilution-adjusted): 53038976.85749087
Buyback yield (%): 0
Retained earnings: 392035322.7771011
Inventory turnover: 11.997907066727636
Receivables turnover: 3.9696660415211826
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.637508885465504
FCF margin (%): 2.5619528381813046
Rule of 40 score: 2.5619528381813046
Financial ratios for KEC.NS — annual report dated 2024-03-31
Total revenue: 2349842906.82336
Gross profit: 476089459.1677659
Operating income: 142796498.38110086
Net income: 41585321.98105288
Capital expenditures: 455690.1307111164
Operating cash flow: 37310229.04424991
Depreciation & amortization: 22228084.902266458
Net tangible assets: 456156613.5028181
Owner earnings: 63357716.752608225
Return on net tangible assets (%): 13.889465783710882
Capex to operating income (%): 0.31911856094324725
Buffett classification: The Great
Stock price: 8.237284069097889
P/E ratio: 52.729302425334744
Shares outstanding: 266200000
Book value: 491150017.9877682
P/B ratio: 4.464552456248648
Market cap (USD): 2192765019.193858
Debt to equity: 0.967109407427302
Current ratio: 1.1117506209705716
Quick ratio: 1.0282680941535878
Effective tax rate (%): 18.689769982883536
Interest coverage ratio: 1.8320537870978664
COGS to revenue (%): 79.73951970213326
SG&A to revenue (%): 3.3537565564057576
Free cash flow (dilution-adjusted): 8843986.089459168
Buyback yield (%): 0
Retained earnings: 418642523.08430266
Inventory turnover: 12.878184470580479
Receivables turnover: 4.737041352601882
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.474897560346587
FCF margin (%): 0.37636499290137354
Revenue growth (%): 13.50495543290374
Rule of 40 score: 13.881320425805114
Financial ratios for KEC.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 569897276.6364071
Buffett classification: The Gruesome
Stock price: 12.327281414237936
Shares outstanding: 266200000
Book value: 603941710.4634497
P/B ratio: 5.433508326411138
Market cap (USD): 3281522312.4701385
Debt to equity: 0.8528024999011113
Current ratio: 1.1841514339880443
Quick ratio: 1.097579856555369
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEC.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.886000699382212
Shares outstanding: 266200000
Market cap (USD): 3696453386.1755447
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEC.NS — quarterly report dated 2025-03-31
Total revenue: 803380874.4447042
Gross profit: 173086275.42670095
Operating income: 57552022.44563946
Net income: 31352583.58662614
Capital expenditures: 0
Depreciation & amortization: 5439560.439560439
Net tangible assets: 592050502.6888006
Owner earnings: 36792144.02618658
Return on net tangible assets (%): 6.214359055366874
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.07737192204458
P/E ratio: 19.267920927248667
Shares outstanding: 266200000
Book value: 625140285.2466681
P/B ratio: 3.8653666427765163
Market cap (USD): 2416396405.6482673
Debt to equity: 0.7400686308427382
Current ratio: 1.1947238162850775
Quick ratio: 1.1244416671596758
Effective tax rate (%): 21.61854103343465
Interest coverage ratio: 2.8901021486438885
COGS to revenue (%): 78.45526562399958
Buyback yield (%): 0
Retained earnings: 460348375.02922606
Inventory turnover: 4.727513459481262
Receivables turnover: 1.3605194908039833
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.269724376117075
Rule of 40 score: 0
Financial ratios for KEC.NS — annual report dated 2025-03-31
Total revenue: 2553974748.6555996
Gross profit: 577085574.0004675
Operating income: 154339490.2969371
Net income: 66722001.40285246
Capital expenditures: 3904606.0322656063
Operating cash flow: 48991115.267711006
Depreciation & amortization: 21472995.090016365
Net tangible assets: 592050502.6888006
Owner earnings: 84290390.46060322
Return on net tangible assets (%): 14.237027091067056
Capex to operating income (%): 2.5298813834057956
Buffett classification: The Great
Stock price: 9.07737192204458
P/E ratio: 36.215886137147
Shares outstanding: 266200000
Book value: 625140285.2466681
P/B ratio: 3.8653666427765163
Market cap (USD): 2416396405.6482673
Debt to equity: 0.7400686308427382
Current ratio: 1.1947238162850775
Quick ratio: 1.1244416671596758
Effective tax rate (%): 21.546687926981814
Interest coverage ratio: 1.9895115960156122
COGS to revenue (%): 77.40441348121226
SG&A to revenue (%): 2.7369808712528667
Free cash flow (dilution-adjusted): 27653729.24947393
Buyback yield (%): 0
Retained earnings: 460348375.02922606
Inventory turnover: 14.827622187538363
Receivables turnover: 4.325137098849756
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.177240535927865
FCF margin (%): 1.082772226468986
Revenue growth (%): 8.6870420673438
Rule of 40 score: 9.769814293812786
Financial ratios for KEC.NS — quarterly report dated 2025-06-30
Total revenue: 587746314.0650597
Gross profit: 134130587.4093143
Operating income: 35600280.83313831
Net income: 14579920.430610813
Capital expenditures: 0
Depreciation & amortization: 5366253.21787971
Owner earnings: 19946173.648490522
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.679733208518607
P/E ratio: 61.89396900810786
Shares outstanding: 266200000
Market cap (USD): 2842944980.107653
Effective tax rate (%): 21.392972052236452
Interest coverage ratio: 2.013234515616728
COGS to revenue (%): 77.17882967540535
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -26.84088795724579
Rule of 40 score: -26.84088795724579
Financial ratios for KEC.NS — quarterly report dated 2025-09-30
Total revenue: 686759864.712514
Gross profit: 150497181.51071027
Operating income: 42822998.87260428
Net income: 18122886.133032694
Capital expenditures: 0
Depreciation & amortization: 5701240.135287486
Net tangible assets: 603261555.806088
Owner earnings: 23824126.26832018
Return on net tangible assets (%): 3.9492200421235184
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.841600901916573
P/E ratio: 40.89951140636622
Shares outstanding: 266200000
Book value: 636177001.1273959
P/B ratio: 4.118090021247977
Market cap (USD): 2619834160.090192
Debt to equity: 0.9406580670542929
Current ratio: 1.1933397259640934
Quick ratio: 1.109910695718478
Effective tax rate (%): 24.523429429993428
Interest coverage ratio: 2.2149396466266253
COGS to revenue (%): 78.08590902822922
Buyback yield (%): 0
Inventory turnover: 3.2934175269509582
Receivables turnover: 1.1721932295755784
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.028086847363265
Revenue growth (%): 16.846307374118936
Rule of 40 score: 16.846307374118936
Financial ratios for KEC.NS — quarterly report dated 2025-12-31
Total revenue: 668525119.7504735
Gross profit: 149533251.6430879
Operating income: 42288069.510972485
Net income: 14198507.296424195
Capital expenditures: 0
Depreciation & amortization: 5611005.90397683
Owner earnings: 19809513.200401023
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.219895287958115
P/E ratio: 27.962008245595662
Shares outstanding: 266200000
Market cap (USD): 2188136125.6544504
Effective tax rate (%): 20.302632401675734
Interest coverage ratio: 2.218183942970667
COGS to revenue (%): 77.63236605097185
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.6551850070146177
Rule of 40 score: -2.6551850070146177
Financial ratios for KLIN.SW — annual report dated 2022-03-31
Total revenue: 172400000
Gross profit: 96841304.34782608
Operating income: -17682608.695652172
Net income: -23561956.52173913
Capital expenditures: 1953260.8695652173
Operating cash flow: -59279347.82608695
Depreciation & amortization: 4959782.608695652
Net tangible assets: 112925000
Owner earnings: -20555434.782608695
Return on net tangible assets (%): -18.202731709195213
Buffett classification: The Gruesome
Stock price: 15.92391304347826
Shares outstanding: 8840000
Book value: 113829347.82608697
P/B ratio: 1.2366528842756603
Market cap (USD): 140767391.3043478
Debt to equity: 0
Current ratio: 1.4765108527985895
Quick ratio: 0.5604616571176729
Interest coverage ratio: -26.23870967741935
COGS to revenue (%): 43.82754968223544
Free cash flow (dilution-adjusted): -71860869.56521739
Buyback yield (%): 0
Retained earnings: 35815217.391304344
Inventory turnover: 0.5225634279270813
Receivables turnover: 3.9107429050472176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.675112586290183
FCF margin (%): -41.6826389589428
Rule of 40 score: -41.6826389589428
Financial ratios for KLIN.SW — annual report dated 2023-03-31
Total revenue: 339517582.4175824
Gross profit: 180579120.8791209
Operating income: 25469230.769230768
Net income: 22807692.307692308
Capital expenditures: 19216483.516483516
Operating cash flow: 17256043.956043955
Depreciation & amortization: 4750549.450549451
Net tangible assets: 138326373.62637362
Owner earnings: 8341758.241758242
Return on net tangible assets (%): 6.030490081587582
Capex to operating income (%): 75.44979937006515
Buffett classification: The Gruesome
Stock price: 17.0989010989011
P/E ratio: 6.62733799084558
Shares outstanding: 8840000
Book value: 139130769.23076922
P/B ratio: 1.086418816987734
Market cap (USD): 151154285.7142857
Debt to equity: 0
Current ratio: 1.6485398342086945
Quick ratio: 0.7184316269062837
Effective tax rate (%): 3.2851817334575957
Interest coverage ratio: 18.96644844517185
COGS to revenue (%): 46.81302818155043
SG&A to revenue (%): 4.1105511698887565
Free cash flow (dilution-adjusted): -2873626.3736263737
Buyback yield (%): 0
Retained earnings: 60259340.65934066
Inventory turnover: 1.2300064632445489
Receivables turnover: 4.342572420481538
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.667130742943932
FCF margin (%): -0.8463851424613464
Revenue growth (%): 96.93595267841206
Rule of 40 score: 96.08956753595072
Financial ratios for KLIN.SW — annual report dated 2024-03-31
Total revenue: 337218888.8888889
Gross profit: 194490000
Operating income: 16750000
Net income: 19116666.666666668
Capital expenditures: 8331111.111111111
Operating cash flow: 26095555.555555556
Depreciation & amortization: 5711111.111111111
Net tangible assets: 155720000
Owner earnings: 16496666.666666668
Return on net tangible assets (%): 10.593800839112937
Capex to operating income (%): 49.7379767827529
Buffett classification: The Good
Stock price: 17.054945054945055
P/E ratio: 7.886611034998131
Shares outstanding: 8840000
Book value: 156391111.11111113
P/B ratio: 0.964029945273551
Market cap (USD): 150765714.2857143
Debt to equity: 0
Current ratio: 1.7193855659486827
Quick ratio: 0.8267945047315167
Effective tax rate (%): 23.71979605409
Interest coverage ratio: 8.237704918032787
COGS to revenue (%): 42.325294813457795
SG&A to revenue (%): 3.393773249817955
Free cash flow (dilution-adjusted): 16888888.888888888
Buyback yield (%): 0
Retained earnings: 78700000
Inventory turnover: 1.122719923087008
Receivables turnover: 3.798270424509411
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.976366700210193
FCF margin (%): 5.008286737595429
Revenue growth (%): -0.6770469771625165
Rule of 40 score: 4.331239760432913
Financial ratios for KLIN.SW — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 154323809.52380952
Buffett classification: The Gruesome
Stock price: 17.857142857142858
Shares outstanding: 8840000
Book value: 155916666.6666667
P/B ratio: 1.0124455982286018
Market cap (USD): 157857142.85714287
Debt to equity: 0
Current ratio: 1.595814439656793
Quick ratio: 0.5752175122761899
Buyback yield (%): 0
Retained earnings: 75458333.33333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KLIN.SW — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 161323863.63636363
Buffett classification: The Gruesome
Stock price: 13.113636363636363
Shares outstanding: 8840000
Book value: 162923863.63636366
P/B ratio: 0.7115258800471497
Market cap (USD): 115924545.45454545
Debt to equity: 0
Current ratio: 1.7979202276652677
Quick ratio: 0.863767752789884
Buyback yield (%): 0
Retained earnings: 86122727.27272727
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KLIN.SW — annual report dated 2025-03-31
Total revenue: 351214772.72727275
Gross profit: 205787500
Operating income: 17510227.272727273
Net income: 11346590.909090908
Capital expenditures: 9636363.636363637
Operating cash flow: 21556818.181818184
Depreciation & amortization: 6392045.454545454
Net tangible assets: 161323863.63636363
Owner earnings: 8102272.727272727
Return on net tangible assets (%): 5.022364667347586
Capex to operating income (%): 55.03277305470829
Buffett classification: The Good
Stock price: 13.113636363636363
P/E ratio: 10.216685027541313
Shares outstanding: 8840000
Book value: 162923863.63636366
P/B ratio: 0.7115258800471497
Market cap (USD): 115924545.45454545
Debt to equity: 0
Current ratio: 1.7979202276652677
Quick ratio: 0.863767752789884
Effective tax rate (%): 33.53524595620049
Interest coverage ratio: 8.452550740537575
COGS to revenue (%): 41.40693502098237
SG&A to revenue (%): 2.5884187673302725
Free cash flow (dilution-adjusted): 11302272.727272727
Buyback yield (%): 0
Retained earnings: 86122727.27272727
Inventory turnover: 1.225999904200795
Receivables turnover: 4.403758744995227
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.15317263255438
FCF margin (%): 3.2180516324833612
Revenue growth (%): 4.150385491304846
Rule of 40 score: 7.3684371237882065
Financial ratios for KLIN.SW — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 148051250
Buffett classification: The Gruesome
Stock price: 14.875
Shares outstanding: 8840000
Book value: 149867500
P/B ratio: 0.8774083774000366
Market cap (USD): 131495000
Debt to equity: 0
Current ratio: 1.5028423427434916
Quick ratio: 0.5493513818386915
Buyback yield (%): 0
Retained earnings: 68342500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LSF.AX — annual report dated 2021-06-30
Total revenue: 572456390.9774436
Net income: 386610526.31578946
Capital expenditures: 0
Net tangible assets: 1183692481.2030075
Owner earnings: 386610526.31578946
Return on net tangible assets (%): 32.66139917716385
Buffett classification: The Gruesome
Stock price: 1.5789473684210527
P/E ratio: 2.592039125462862
Shares outstanding: 634669420
Book value: 1183692481.2030075
P/B ratio: 0.8465962455956924
Market cap (USD): 1002109610.5263158
Debt to equity: 0
Effective tax rate (%): 29.068062336100116
COGS to revenue (%): 0
SG&A to revenue (%): 0.04334309209619014
Free cash flow (dilution-adjusted): -378400000
Buyback yield (%): 5.441002806213816
Retained earnings: -110143609.02255638
Receivables turnover: 17.203312470343672
Capitalized R&D asset: 0
FCF margin (%): -66.10110498616305
Rule of 40 score: -66.10110498616305
Financial ratios for LSF.AX — annual report dated 2022-06-30
Total revenue: 164608965.5172414
Net income: 97291724.13793103
Capital expenditures: 0
Net tangible assets: 1162362758.6206896
Owner earnings: 97291724.13793103
Return on net tangible assets (%): 8.370168728855495
Buffett classification: The Gruesome
Stock price: 1.4965517241379311
P/E ratio: 9.762553014396802
Shares outstanding: 634669420
Book value: 1162362758.6206899
P/B ratio: 0.8171421595489804
Market cap (USD): 949815614.7586207
Debt to equity: 0
Effective tax rate (%): 23.042555628897023
COGS to revenue (%): 0
SG&A to revenue (%): 0.15501732423339742
Free cash flow (dilution-adjusted): 266000000
Buyback yield (%): 0
Retained earnings: -101028275.86206897
Receivables turnover: 2.9546557401401303
Capitalized R&D asset: 0
FCF margin (%): 161.59508636978754
Revenue growth (%): -71.24515192569011
Rule of 40 score: 90.34993444409743
Financial ratios for LSF.AX — annual report dated 2023-06-30
Total revenue: 185776821.192053
Net income: 108127152.3178808
Capital expenditures: 0
Net tangible assets: 1195076821.192053
Owner earnings: 108127152.3178808
Return on net tangible assets (%): 9.04771562802358
Buffett classification: The Gruesome
Stock price: 1.6357615894039736
P/E ratio: 9.601361332010388
Shares outstanding: 634669420
Book value: 1195076821.192053
P/B ratio: 0.8687038697393169
Market cap (USD): 1038167859.2052981
Debt to equity: 0
Effective tax rate (%): 27.21339538864816
COGS to revenue (%): 0
SG&A to revenue (%): 0.13902603351596837
Free cash flow (dilution-adjusted): 338276821.19205296
Buyback yield (%): 0
Retained earnings: -97013907.28476821
Receivables turnover: 12.802838756788828
Capitalized R&D asset: 0
FCF margin (%): 182.087743250999
Revenue growth (%): 12.859479195617961
Rule of 40 score: 194.94722244661696
Financial ratios for LSF.AX — annual report dated 2024-06-30
Total revenue: 190452666.66666666
Net income: 113526666.66666667
Capital expenditures: 0
Net tangible assets: 1281264666.6666667
Owner earnings: 113526666.66666667
Return on net tangible assets (%): 8.860516458478264
Buffett classification: The Gruesome
Stock price: 1.9400000000000002
P/E ratio: 10.845545905220506
Shares outstanding: 634669420
Book value: 1281264666.6666667
P/B ratio: 0.9609713799438785
Market cap (USD): 1231258674.8000002
Debt to equity: 0
Effective tax rate (%): 24.974777180066702
COGS to revenue (%): 0
SG&A to revenue (%): 0.14246759474795137
Free cash flow (dilution-adjusted): -163110000
Buyback yield (%): 0
Retained earnings: -97660666.66666667
Receivables turnover: 9.964040319486589
Capitalized R&D asset: 0
FCF margin (%): -85.64332695087845
Revenue growth (%): 2.5169154282061137
Rule of 40 score: -83.12641152267233
Financial ratios for LTH — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 233893000
Buffett classification: The Gruesome
Stock price: 17.21
Shares outstanding: 222602738
Market cap (USD): 3830993120.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LTH — annual report dated 2022-12-31
Total revenue: 1822557000
Gross profit: 754349000
Operating income: 110619000
Net income: -1793000
Capital expenditures: 351850000
Operating cash flow: 200969000
Depreciation & amortization: 228883000
Net tangible assets: 717681000
Owner earnings: -124760000
Return on net tangible assets (%): -17.3837679972021
Capex to operating income (%): 318.0737486326942
Buffett classification: The Gruesome
Stock price: 11.96
Shares outstanding: 222602738
Book value: 2124261000
P/B ratio: 1.2532964388462624
Market cap (USD): 2662328746.48
Debt to equity: 1.8995961419053498
Current ratio: 0.2864763470527278
Quick ratio: 0.18666348932895502
Interest coverage ratio: 0.9742991271567859
COGS to revenue (%): 58.61040285708485
SG&A to revenue (%): 25.195480854645425
Free cash flow (dilution-adjusted): -427500000
Buyback yield (%): 0
Retained earnings: -652876000
Inventory turnover: 23.397393494688423
Receivables turnover: 79.25539224212906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7934463550897
FCF margin (%): -23.456056518396956
Rule of 40 score: -23.456056518396956
Financial ratios for LTH — annual report dated 2023-12-31
Total revenue: 2216593000
Gross profit: 1032223000
Operating income: 225210000
Net income: 76063000
Capital expenditures: 126000000
Operating cash flow: 463004000
Depreciation & amortization: 244397000
Net tangible assets: 846626000
Owner earnings: 194460000
Return on net tangible assets (%): 22.96881976220905
Capex to operating income (%): 55.947782070067944
Buffett classification: The Good
Stock price: 15.08
P/E ratio: 44.13248608443001
Shares outstanding: 222602738
Book value: 2254112000
P/B ratio: 1.4892114007822148
Market cap (USD): 3356849289.04
Debt to equity: 1.8901021777090048
Current ratio: 0.31321720465615455
Quick ratio: 0.21845196860003088
Effective tax rate (%): 19.756303407532442
COGS to revenue (%): 53.43200127402731
SG&A to revenue (%): 21.485811784120944
Free cash flow (dilution-adjusted): -285133000
Buyback yield (%): 0
Retained earnings: -576813000
Inventory turnover: 22.429975569569912
Receivables turnover: 37.38939680183523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4781773368506874
FCF margin (%): -12.863570353240311
Revenue growth (%): 21.619954821714767
Rule of 40 score: 8.756384468474456
Financial ratios for LTH — quarterly report dated 2024-09-30
Capital expenditures: 74292000
Buffett classification: The Gruesome
Stock price: 24.42
Shares outstanding: 222602738
Market cap (USD): 5435958861.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LTH — quarterly report dated 2024-12-31
Capital expenditures: 293000
Buffett classification: The Gruesome
Stock price: 22.12
Shares outstanding: 222602738
Market cap (USD): 4923972564.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LTH — annual report dated 2024-12-31
Total revenue: 2620995000
Gross profit: 1228574000
Operating income: 357483000
Net income: 156240000
Capital expenditures: 222998000
Operating cash flow: 575117000
Depreciation & amortization: 274681000
Net tangible assets: 1203348000
Owner earnings: 207923000
Return on net tangible assets (%): 17.278709068365924
Capex to operating income (%): 62.38002926013265
Buffett classification: The Good
Stock price: 22.12
P/E ratio: 31.51544140143369
Shares outstanding: 222602738
Book value: 2610350000
P/B ratio: 1.8863265709809032
Market cap (USD): 4923972564.56
Debt to equity: 1.5279196276361406
Current ratio: 0.32873296250934914
Quick ratio: 0.21285976047052219
Effective tax rate (%): 25.160944206008583
COGS to revenue (%): 53.125664108477885
SG&A to revenue (%): 20.068409134698843
Free cash flow (dilution-adjusted): -452000
Buyback yield (%): 0
Retained earnings: -420573000
Inventory turnover: 23.104586333919624
Receivables turnover: 68.04597850355678
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.389921708983459
FCF margin (%): -0.01724535910980372
Revenue growth (%): 18.24430556263599
Rule of 40 score: 18.227060203526186
Financial ratios for LTH — quarterly report dated 2025-03-31
Total revenue: 706041000
Gross profit: 335054000
Operating income: 107670000
Net income: 76142000
Capital expenditures: 142482000
Operating cash flow: 183856000
Depreciation & amortization: 70919000
Net tangible assets: 1327592000
Owner earnings: 4579000
Return on net tangible assets (%): 0.34491018324907047
Capex to operating income (%): 132.33212594037334
Buffett classification: The Gruesome
Stock price: 30.2
P/E ratio: 22.0725837500985
Shares outstanding: 222602738
Book value: 2734471000
P/B ratio: 2.458465526824018
Market cap (USD): 6722602687.599999
Debt to equity: 1.4674618966520399
Current ratio: 0.4282578869921795
Quick ratio: 0.3086943959158134
Effective tax rate (%): 7.759215961815692
COGS to revenue (%): 52.54468224933113
SG&A to revenue (%): 19.688941577047224
Free cash flow (dilution-adjusted): 29465000
Buyback yield (%): 0
Retained earnings: -344431000
Inventory turnover: 5.937311951859676
Receivables turnover: 21.28938005065734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5856014955048114
FCF margin (%): 4.173270390812998
Rule of 40 score: 4.173270390812998
Financial ratios for LTH — quarterly report dated 2025-06-30
Total revenue: 761469000
Gross profit: 357544000
Operating income: 108449000
Net income: 72102000
Capital expenditures: 222004000
Operating cash flow: 195698000
Depreciation & amortization: 72988000
Net tangible assets: 1462643000
Owner earnings: -76914000
Return on net tangible assets (%): -5.258562752496679
Capex to operating income (%): 204.7082038561905
Buffett classification: The Gruesome
Stock price: 30.33
P/E ratio: 45.54343544116457
Shares outstanding: 222602738
Book value: 2869243000
P/B ratio: 2.353073979283037
Market cap (USD): 6751541043.54
Debt to equity: 1.4240484336809396
Current ratio: 0.6471780929838321
Quick ratio: 0.5308269645375604
Effective tax rate (%): 27.590258599045946
COGS to revenue (%): 53.04549495777241
SG&A to revenue (%): 19.024280699542594
Free cash flow (dilution-adjusted): -42685000
Buyback yield (%): 0
Retained earnings: -272329000
Inventory turnover: 6.104905991173448
Receivables turnover: 14.247446020282155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.54232019146848
FCF margin (%): -5.605612309890487
Revenue growth (%): 7.850535592125669
Rule of 40 score: 2.244923282235182